Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2316052
Max Phase: Preclinical
Molecular Formula: C22H32N8
Molecular Weight: 408.55
Molecule Type: Small molecule
Associated Items:
ID: ALA2316052
Max Phase: Preclinical
Molecular Formula: C22H32N8
Molecular Weight: 408.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(NCCCN1CCN(CCCNC(=N)c2ccccn2)CC1)c1ccccn1
Standard InChI: InChI=1S/C22H32N8/c23-21(19-7-1-3-9-25-19)27-11-5-13-29-15-17-30(18-16-29)14-6-12-28-22(24)20-8-2-4-10-26-20/h1-4,7-10H,5-6,11-18H2,(H2,23,27)(H2,24,28)
Standard InChI Key: NDKJXDNCAVZVKY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.55 | Molecular Weight (Monoisotopic): 408.2750 | AlogP: 1.40 | #Rotatable Bonds: 10 |
Polar Surface Area: 104.02 | Molecular Species: BASE | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.01 | CX LogP: 0.49 | CX LogD: -2.68 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.27 | Np Likeness Score: -0.82 |
1. Arya S, Kumar N, Roy P, Sondhi SM.. (2013) Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity., 59 [PMID:23202484] [10.1016/j.ejmech.2012.10.046] |
Source(1):